Youming Wang completed her PhD program at the University of Science and Technology of China in April 2025. During her doctoral journey, her research was centered on investigating the cytokine release syndrome (CRS) that occurs following CAR-T cell therapy. She conducted this research through an in-depth exploration of the proteome and a comprehensive analysis of the underlying mechanisms. Furthermore, she joined Guomics as a visiting student in 2020. In May 2025, Youming joined the Guomics team as a postdoctoral researcher.